Pro-inflammatory signaling proteins

Pro-inflammatory signaling proteins are a broad class of molecules that coordinate the body's response to infection, injury, and cellular stress [4, 8]. This category includes secreted cytokines such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1), and interleukin-6 (IL-6), as well as intracellular signaling components like the NF-kappaB transcription factor and various protein kinases [4, 5, 10]. These proteins promote the activation and recruitment of immune cells, the production of secondary inflammatory mediators, and the regulation of cell death pathways [4, 8]. Dysregulation or chronic overproduction of these proteins is a hallmark of many pathological conditions, including rheumatoid arthritis, inflammatory bowel disease, and several types of cancer [2, 6, 9]. Therapeutic intervention typically involves the use of monoclonal antibodies to neutralize specific cytokines, receptor antagonists to block signal initiation, or small-molecule inhibitors to interrupt downstream intracellular cascades like the JAK/STAT pathway [2, 4, 6]. While these therapies are highly effective in managing chronic inflammation, they are often associated with significant safety concerns, such as an increased risk of opportunistic infections and the potential for malignancy due to systemic immunosuppression [6, 7].

Other names

Pro-inflammatory cytokinesPro-inflammatory mediatorsInflammatory signaling moleculesInflammatory cascade proteins

Neutralization of circulating pro-inflammatory cytokines, competitive blockade of cytokine receptors, or small-molecule inhibition of intracellular signaling enzymes and transcription factors.